Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00570024 · ClinicalTrials.gov registry record · NA

The Effects of Traditional Acupuncture on Mechanisms of Coronary Heart Disease

A NA study, sponsored by Cedars-Sinai Medical Center.

Completed
Registry status
NA
Development phase
145
Enrollment target

NCT00570024: Completed NA study, sponsored by Cedars-Sinai Medical Center.

NCT00570024 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 145 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00570024, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.

COMPLETED
Registry status
NA
Development phase
145 participants
Enrollment target

Study Summary

This research is being done because sudden and unexpected cardiac death remains a significant problem in patients with established coronary heart disease and accounts for 30% of deaths in this group (150,000 deaths annually) despite recognition and treatment of their heart disease. A large body of evidence implicates psychosocial stress as a risk factor and trigger for reduced blood flow in the heart, heart attack and sudden cardiac death, yet the specific mechanisms of this relationship remain under investigation. The nervous system, which plays a role in regulation of the heart, can influence cardiac arrhythmias (irregular heart beats). There are several studies that suggest that acupuncture improves anginal symptoms (like chest pain or tightness) and blood pressure, while reducing stress and improving overall quality of life. The reason that acupuncture seems to have a positive effect on these factors is thought to be that it helps the arteries and the nervous system to work better. It is possible to measure these effects in a systematic way. The functioning of the artery can be measured by Peripheral Arterial Tonometry, (PAT) a simple monitoring device that measures blood flow using finger probes and a blood pressure cuff. Changes in the nervous system can be measured by using a 24-hour Holter monitor to record the heart rate. The 24-hour Holter monitor will also show if oxygen flow to the heart is decreased, as would happen during stress, by recording a continuous electrocardiogram (ECG). Feelings about stress can be established by questionnaires. The purpose of this study is to compare three groups of people with known coronary heart disease. One group will receive traditional acupuncture, one group will receive alternative acupuncture, and a third group will receive usual care only.

Primary Outcome

Holter monitoring will be recorded during the provocative procedures and during a 24-hour period during which subjects will document their activities and any anginal symptoms in a diary.

Interventions

  • PROCEDURE Traditional Acupuncture
  • PROCEDURE AA

Trial Details

FieldValue
Enrollment Target 145 participants
Start Date 2006-01
Est. Completion 2010-03
Phase NA
Cedars-Sinai Medical Center

339 total trials

What the finished NCT00570024 record still lists

NCT00570024 is an interventional study that assigns participants to a tested intervention. The registered 145 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 2 interventions - of which Traditional Acupuncture is the first listed.

NCT00570024 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00570024 about?

NCT00570024 is a clinical study titled "The Effects of Traditional Acupuncture on Mechanisms of Coronary Heart Disease". This research is being done because sudden and unexpected cardiac death remains a significant problem in patients with established coronary heart disease and accounts for 30% of deaths in this group (150,000 deaths annually) despite recognition and treatment of their heart disease. A large body of e...

What is the current status of trial NCT00570024?

This trial is currently completed. It is a NA study. The enrollment target is 145 participants. The study started on 2006-01. Estimated completion is 2010-03.

What interventions are being tested in trial NCT00570024?

The interventions under investigation include: Traditional Acupuncture (PROCEDURE), AA (PROCEDURE).

Who is sponsoring clinical trial NCT00570024?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00570024's enrollment target sits among peer trials

145 705th of 2000 higher than 1,295 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02688959 · 145 participants · NA

    Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)

  • NCT03586609 · 145 participants · Phase 2

    Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia

  • NCT03767595 · 145 participants · NA

    ProACT Post-Approval Study

  • NCT03808337 · 145 participants · Phase 2

    Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00570024, the US trial registry maintained by the National Library of Medicine. NCT00570024 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.